Capital Asset Advisory Services LLC purchased a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 9,317 shares of the financial services provider’s stock, valued at approximately $1,627,000.
Several other hedge funds also recently modified their holdings of the stock. Headlands Technologies LLC acquired a new stake in shares of Marsh & McLennan Companies in the second quarter valued at about $29,000. Solstein Capital LLC bought a new position in Marsh & McLennan Companies in the fourth quarter valued at approximately $25,000. SHP Wealth Management acquired a new position in shares of Marsh & McLennan Companies during the 4th quarter worth approximately $26,000. KERR FINANCIAL PLANNING Corp bought a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth approximately $27,000. Finally, Golden State Wealth Management LLC acquired a new stake in shares of Marsh & McLennan Companies in the 4th quarter valued at approximately $27,000. Institutional investors own 87.99% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on MRSH. Keefe, Bruyette & Woods boosted their target price on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a report on Friday, April 17th. Citigroup raised shares of Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective for the company in a research report on Wednesday, May 6th. Wells Fargo & Company lowered their price objective on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 9th. Barclays cut their target price on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. Finally, UBS Group lowered their price target on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating on the stock in a research report on Tuesday, June 9th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $200.19.
Marsh & McLennan Companies Stock Up 3.1%
MRSH stock opened at $171.84 on Thursday. Marsh & McLennan Companies, Inc. has a one year low of $156.60 and a one year high of $217.07. The firm has a market cap of $83.02 billion, a price-to-earnings ratio of 21.48, a P/E/G ratio of 2.43 and a beta of 0.61. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last issued its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $3.21 by $0.08. The company had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. Marsh & McLennan Companies’s revenue was up 7.6% compared to the same quarter last year. Research analysts forecast that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current year.
Insiders Place Their Bets
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the transaction, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This represents a 12.48% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by corporate insiders.
Marsh & McLennan Companies Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading
- Five stocks we like better than Marsh & McLennan Companies
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
